LISTE DES ANALYSES HORS-QUEBEC List for testing done out of Québec LABORATOIRE CLINIQUES CUSM MUHC CLINICAL LABS

Size: px
Start display at page:

Download "LISTE DES ANALYSES HORS-QUEBEC List for testing done out of Québec LABORATOIRE CLINIQUES CUSM MUHC CLINICAL LABS"

Transcription

1 APPELATION APPROUVÉE DE OU DE LA MALADIE ASSOCIÉE 11-ß-prostaglandin F2a urine, collect 4 C, 25 ml 50% Hac 21-Hydroxylase Antibodies, Serum autoimmume adrenal Red Top; store serum failure frozen a1-acid glycoprotein Obsolete name: orsomucoid serum Hospitals In Common Acetaminophen quantitation; to determine clearance serum Hospitals-In-Common Acetazolamide Red Top (not SST) Prometheus Adalimumab (Anser ADA) or Red Top Quote Therapeutics and Adenosine Deaminase ACD (yellow), 4 C ADH Sacre Coeur ADmark Early Onset Alzheimer's Evaluation ; ; PSEN1; PSEN2; APP Alzheimer's disease ADmark Phospho-Tau/Total-Tau/Ab42 CSF Analysis & Interpretation (Symptomatic) Alzheimer's disease CSF Adrenal hyperplasia due to 21-hydroyxlase deficiency (201910) CYP21A Adrenal hyperplasia, congenital, due to steroid 11-beta-hydroxylase deficiency; Hypoaldosteronism congenital due to CMO I deficiency CYP11B1; CYP11B ; Alexander disease (203450) GFAP alpha-actin (skeletal muscle form)-related myopathy via the ACTA1 gene ACTA nemaline myopathy (NEM3; OMIM #161800) and congenital fiber-type disproportion (CFTD1; OMIM #255310) & MLPA gene Alberta Mol Dx Laboratory (Calgary) GeneDx File Name: Gilfix-Lab Send Out List_Revised Updated Page 1 of 30

2 APPELATION APPROUVÉE DE OU DE LA MALADIE ASSOCIÉE Alpha-Subunit Pituitary Tumor Marker Alternate name: Alpha Glycoprotein Subunit Red top Aminolevulinic acid dehydratase Aminolevulinic Acid Dehydratase Deficiency Porphyria (612740) Green Top, 4 C only Amphiphysin Antdiuretic Hormome Anticorps anti-21 hydroxylase Anti-Enterocyte Antibody Paraneoplastic Disease Profile autoimmume adrenal failure Plasma (EDTA); handle at 4 C; freeze plasma in plastic container ; store serum at -20 C Anti-HMGCR statin-related myopathy Serum Mitogen Advanced Hopital Sacre-Coeur, QC CHUM The Children's Hospital of Philadelphia Mitogen Advanced Anti-myelin associated glycoproteins (anti-mag) WB Mitogen Advanced Anti-p140/p155/TRIM28 Paraneoplastic Disease Profile Mitogen Advanced Anti-RNA pol I/III Mitogen Advanced Autoimmune Inflammatory Myopathy/Myositis Profile Jo-1, Mi2, PL7, PL12, Pm/Scl75, PM/Scl100, Ku, SRP, Ro52, EJ, OJ Mitogen Advanced File Name: Gilfix-Lab Send Out List_Revised Updated Page 2 of 30

3 APPELATION APPROUVÉE DE OU DE LA MALADIE ASSOCIÉE Autoimmune Neurological Diseases Profile GM1 (IgG,IgM), GM2, GD1a, GT1b (IgG,IgM), GM3 (IgG, IgM), GQ1b (IgG,IgM), GD1b (IgG,IgM) Mitogen Advanced Autoimmune Paraneoplastic Diseases Profile encephalomyelitis) (paraneoplastic ataxia, Amphiphysin, Ri, Yo. Hu, PNMA2 (Ma2/Ta), CV2/CRMP-5, Recoverin, SOX1, tintin ; CSF Mitogen Advanced Autoimmune polyendocrinopathy syndrome, type I (240300) AIRE Autosomal dominant lateral temporal lobe epilepsy (Epilepsy, familial temporal lobe, 1) (600512) AUTOSOMAL RECESSIVE LIMB GIRDLE MUSCULAR DYSTROPHY SANGER SEQUENCING PANEL (253600; ;254130;607155;611307; ; ; ; ; ; ; ) LGI SGCD (601411); TRIM32 (602290); SGCG (608896); CAPN3 (114240); DYSF (603009); FKFP (606596); SGCA (60119); SGCB (600900); TTN (188840); TCAP (604488); ANO5 (608662) Azithromycin TDM Serum gene GeneDx National Jewish Health Laboratories File Name: Gilfix-Lab Send Out List_Revised Updated Page 3 of 30

4 APPELATION APPROUVÉE DE OU DE LA MALADIE ASSOCIÉE Baller-Gerold syndrome (218600) RECQL Barium Alternate: Hospitals-In- Common Urine - metal free container gene INSPQ Benign Recurrent Intrahepatic Cholestasis Type 2 (605479) ABCB Cinncinatti Children's Hospital (Division of Human Genetics Diagnostic Laboratories) Bile acids (total) bile salts serum, fasting Hospitals-In-Common Birt-Hogg-Dubé Syndrome (135150) FLCN Alberta Mol Dx Laboratory (Calgary) Birt-Hogg-Dubé Syndrome (135150) FLCN on (MLPA) Alberta Mol Dx Laboratory (Calgary) Breast-Ovarian Cancer, Familial, type 1 (604370) BRCA Mount Sinai Hospital Breast-Ovarian Cancer, Familial, type 2 (612555) BRCA Mount Sinai Hospital Bromide C1q Complement Component. Separate platelet-poor plasma immediately. Freeze as soon as possible. Store and send frozen. If the specimen thaws, it is unsuitable for analysis. Hospitals-In-Common File Name: Gilfix-Lab Send Out List_Revised Updated Page 4 of 30

5 APPELATION APPROUVÉE DE OU DE LA MALADIE ASSOCIÉE C9ORF72 (FTD) DNA Test C9orf CACNA1A Full Gene Sequencing Analysis (MOL033) CACNA1A CACNB4 Full Gene Sequencing Analysis (MOL227) CACNB Amyotrophic lateral sclerosis and/or frontotemporal dementia Familial hemiplegic migraine 1 (141500); episodic ataxia type 2 (108500) Episodic ataxia, type 5 (613855) repeat expansion CADASIL (125310) NOTCH Medical Neurogenetics Medical Neurogenetics London Laboratories Service Group Calpain 3 DNA Sequencing Test CAPN LGMD2A (253600), Calpainopathy Calprotectin random stool CASPR2 Antibody Test Paraneoplastic Disease Red Top or Cathartic Laxatives Profile Mg, Pi Stool CDKN2A (p16) & CDK4 (Exon2) Sequencing CDKN2A; CDK ; CEREBRAL CAVERNOUS MALFORMATIONS VIA THE CCM2 GENE (603284) CEREBRAL CAVERNOUS MALFORMATIONS VIA THE KRIT1/CCM1 GENE CEREBRAL CAVERNOUS MALFORMATIONS VIA THE PDCD10/CCM3 (603285) CCM KRIT PDCD Melanoma, cutaneous malignant, 3 Cerebral calvernous malformations-2 Cerebral calvernous malformations-1 (116860) Cerebral calvernous malformation-3 Cerebrotendinous xanthomatosis (213700) CYP27A gene GeneDx File Name: Gilfix-Lab Send Out List_Revised Updated Page 5 of 30

6 APPELATION APPROUVÉE DE OU DE LA MALADIE ASSOCIÉE Charcot-Marie-Tooth disease, type 2A2 (609260) MFN Charcot-Marie-Tooth neuropathy, X-linked dominant (302800) GJB London Health Sciences Centre, Molecular Diagnostic Laboratory Laboratory of Human Genetics (QC) Charcot-Marie-Tooth Type 1A (118220) PMP on Laboratory of Human Genetics (QC) Charcot-Marie-Tooth Type 1A (118220) PMP Charcot-Marie-Tooth Type 1B (118200) MPZ Cholestanol Cerebrotendinous xanthomatosis Chondrosarcoma/Exostoses, multiple, type 1 and 2 EXT1 EXT / CLCN1 DNA Sequencing Test CLCN Myotonia congenita ( and ) Cockayne syndrome ERCC6; ERCC ; COL4A5 Sequencing and Deletion Analysis COL4A Alport syndrome (301050) Colorectal cancer (Li-Fraumeni syndrome) (151623) TP Complete PKD Evaluation PKD1; PKD ; and MLPA and & Alberta Mol Dx Laboratory (Calgary) Alberta Mol Dx Laboratory (Calgary) Kennedy Kreiger Institute (Biochemical Genetics) Molecular GeneticsLlaboratory - BC Children s Hospital & BC Women s Hospital DNA Diagnostic Lab - Boston Children's Hospital Children File Name: Gilfix-Lab Send Out List_Revised Updated Page 6 of 30

7 APPELATION APPROUVÉE DE OU DE LA MALADIE ASSOCIÉE Complete Tuberous Sclerosis Evaluation [TSC1 DNA Seq., TSC1 Deletion, TSC2 DNA Seq., TSC2 Deletion] (191100) Cortisol, free Creatine Disorders Panel TSC1; TSC ; GATM (602360); SLC6A8 (300036) Tuberous sclerosis-1 (191100); Tuberous sclerosis-2 (613254) arginine:glycine amidinotransferase deficiency (602360/612718), guanidinoacetate methyltransferase deficiency (601240/612736), creatine transporter (SLC6A8) defect (300036/300352) Red Top or Lavender Top Random urine sequencning and CV2/CRMP-5 Paraneoplastic Disease Profile Mitogen Advanced Cystatin C Serum Hospitals-In-Common Cystic Fibrosis (219700) CFTR & Children Cytochrome P450 2D6 Genotype CYP2D s Dabigratan Serum (Light blue top) Quest File Name: Gilfix-Lab Send Out List_Revised Updated Page 7 of 30

8 APPELATION APPROUVÉE DE OU DE LA MALADIE ASSOCIÉE DARS2 Full Gene Sequencing Analysis (MOL094) DARS Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation (611105) Alternate name: DARS2: Mitochondrial AspartyltRNA Synthetase Deficiency Medical Neurogenetics Desmogelein 1 (DSG1) & Desmogelein 3 (DSG3) Pemphigus Red Top Mayo Med Lab Dexamethasone Red Top Dihydrotestosterone Red Top or Gold Top Hospitals-In-Common Diuretic Screen benzthiazide, bumetanide, chlorothiazide, chlorthalidone, furosemide, hydrochlorothiazide, hydroflumethiazide, and metolazone Random urine Duchene and Becker Muscular Dystrophy ( and ) DMD Ehlers-Danlos syndrome, type I COL5A Ehlers-Danlos syndrome, type I and II COL5A & Ehlers-Danlos syndrome, type I and II COL5A Ehlers-Danlos syndrome, type IV (130050) COL3A & Children Connective Tissue Gene Test Connective Tissue Gene Test Connective Tissue Gene Test Connective Tissue Gene Tests File Name: Gilfix-Lab Send Out List_Revised Updated Page 8 of 30

9 APPELATION APPROUVÉE DE OU DE LA MALADIE ASSOCIÉE Epidermolysis bullosa (226600) COL7A Epilepsy, generalized, with febrile seizures plus, type 7 (613863) SCN9A Ethambutol TDM Serum gene gene National Jewish Health Laboratories Everolimus TDM Facioscapulohumeral Muscular Dystrophy (158900) DUX4 (D4Z4) FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 2 (158901) VIA THE SMCHD1 GENE SMCHD on Childern's Hospital of Eastern Ontario Familial Hemophagocytic Lymphohistiocytosis (FHL), Autosomal Recessive; type 2 (603553), type 3 (608898), type 4 (603552) and type 5 (613101) PRF1; UNC13D (MUNC13-4); STXBP2; RAB27A; STX ; ; ; ; PRF1 and STX11 also at: Children Cinncinatti Children's Hospital (Division of Human Genetics Diagnostic Laboratories) Familial Limb Girdle Myasthenia Syndroma via the DOK7 gene (254300) DOK Fascioscapulohumeral Muscular Dystrophy 1A (FSHD) (158900) DUX4 (FSHMD1A) Fumarase deficiency (606812) FH fumarate hydratase deletion and haplotype and Childern's Hospital of Eastern Ontario Gabapentin Red Top Hospitals-In-Common Gadolium Random urine GeneDx File Name: Gilfix-Lab Send Out List_Revised Updated Page 9 of 30

10 APPELATION APPROUVÉE DE OU DE LA MALADIE ASSOCIÉE Ganglioside (GM1) Antibodies Available as part of profile from Mitogen Advanced ARUP GCK (MODY2) DNA Sequencing and DeletionTest GCK MODY2, Maturity-Onset Diabetes of Young (MODY) (125851) GH-RH Serum or EDTA plasma InterSceince Institute Gitelman syndrome ( ) SLC12A Glucagon ; freeze plasma ASAP Glycogen Storage Disease V (McArdle disease) (232600) PYGM and GQ1b (IgG+IgM) Neurological Disease Profile and Hospitals In Common Emory Molecular Genetics Laboratory Mitogen Advanced Haloperidol Red Top or Green Top Hospitals In Common Hearing Loss: Branchio-Oto-Renal (BOR) Syndrome (115630) EYA Hearing Loss: Non-Syndromic (Connexin 26 & 30) GJB2; GJB ; Hemiplegic Migraine Evaluation CACNA1A; ATP1A2; SCN1A ; ; Familial Hemiplegic Migraine Type I (CACNA1A) DNA Test (141500), Familial Hemiplegic Migraine Type II (ATP1A2) DNA Test (602481), Familial Hemiplegic Migraine Type III (SCN1A) DNA Test (Target Exon Analysis) (609634) and Children Children File Name: Gilfix-Lab Send Out List_Revised Updated Page 10 of 30

11 APPELATION APPROUVÉE DE OU DE LA MALADIE ASSOCIÉE Hereditary Breast Ccancer via the CHEK2 Gene (Li-Fraumeni syndrome) (114480) Hereditary Diffuse Gastric Cance (Gastric cancer, familial diffuse, with or without cleft lip and/or palate) (137215) HEREDITARY DIFFUSE GASTRIC CANCER VIA THE CDH1 GENE (137215) CHEK CDH gene CDH Hereditary hemochromatosis, type 1 (235200) HFE Hereditary Hemorrhagic Telangiectasia (HHT), type 1 (187300) and type 2 (600376) ENG; ACVRL1(ALK1) Hereditary Interstitial Kidney Disease (UMOD) DNA Sequencing Test UMOD ; Lavender Familial juvenile hyperuricemic (or gouty) nephropathy (FJHN) (162000) and Medullary cystic kidney disease type II (MCKD2) (603820) gene and Children Histamine ; freeze plasma ASAP Hospitals In Common Histoplasma Antibody Histoplasmosis Red Top Mayo Med Lab Histoplasma Sereology Alberta Provincial Laboratory HLA-B 1502 Genotype, Carbamazepine Hypersensitivity HLA-B Stevens-Johnson syndrome (608579) and toxic epidermal s necrolysis (608579) HNF4A (MODY1) DNA Sequencing and Deletion Test (125850) HNF1A (TCF1) & MLPA File Name: Gilfix-Lab Send Out List_Revised Updated Page 11 of 30

12 APPELATION APPROUVÉE DE OU DE LA MALADIE ASSOCIÉE Holoprosencephaly-7 (610828) /Basal cell nevus syndrome (109400) /Gorlin syndrome PTCH HTRA1 DNA Sequencing Test (CARASIL) (600142) HTRA Hyperglycosylated hcg First trimester screen for Down syndrome and trisomy 18 Hyperoxaluria, primary, type 1 (259900) AGXT and and MLPA GeneDx Quest Laboratories s Hypertophic Cardiomyopathy Sequencing Panel (192600) ACTC (ACTC1) (102540), CAV3 (601253), GLA (300644), LAMP2 (309060), MTTG (590035), MTTI (590045), MTTK (590060), MTTQ (590030), MYBPC3 (600958), MYH7 (160760), MYL2 (160781), MYL3 (160790), PRKAG2 (602743), TNNC1 (191040), TNNI3 (191044), TNNT2 (191045), TPM1 (191010), TTR (176300), Next Gen GeneDx File Name: Gilfix-Lab Send Out List_Revised Updated Page 12 of 30

13 APPELATION APPROUVÉE DE OU DE LA MALADIE ASSOCIÉE Hypokalemic Periodic Paralysis, type 1 (170400) and type 2 (613345) CACNA1S; SCN4A ; Molecular GeneticsLlaboratory - BC Children s Hospital & BC Women s Hospital IA-2 Autoantibody Test Diabetes, type 1 or Red Top IBD sigi Diagnostic differnetiate among IBD types 2.0 ml Serum (Red Top or SST) and 2.0 ml Whole Blood EDTA / Tube Prometheus Therapeutics & Ibuprofen Red Top ARUP Laboratories IGFBP-1 Not: IGFBP-3 Draw blood in a plain, red-top tube(s). Spin down and separate within one hour. Ship 0.5 ml frozen in a plastic vial. s IGF-II Draw blood in a plain, red-top tube(s). Separate within 1 hour of collection,freeze immediately s Inclusion body myopathy and autospmal recessive, ealrly onset myopathy via the MYH2 gene (605637) MYH Infliximab (Anser IFX) Remicaide or Red Top Quote Prometheus Therapeutics and File Name: Gilfix-Lab Send Out List_Revised Updated Page 13 of 30

14 APPELATION APPROUVÉE DE OU DE LA MALADIE ASSOCIÉE Inherited Focal and Segmental Glomerulosclerosis (FSGS) Evaluation Insulin-Like Growth Factor 1 (IGF-1) INF2; TRPC6; NPHS2;ACTN ; ; ; Glomerulosclerosis, focal segmental, 5 (613237); Glomerulosclerosis, focal segmental, 2 (603965); Nephrotic syndrome, type 2 ( );Glomerulosclero sis, focal segmental, 1 (603278) Integrin alpha 9 ITGA not available Red top Royal Victoria Hospital Interferon Beta Neutralizing Antibodies In MS Patient Treated With IFN Neuro-Immunology Laboratories (UBC) Interleukin-2 JAG1 Gene Sequencing & Del/Dup JAG Alagille syndrome (118450) Draw sufficient blood in a plain, red-top tube(s). Spin down and pour off into a plastic, screw-capped tube. Freeze immediately. s GeneDx Jaundice Chip multiple genes gene chip Cinncinatti Children's Hospital (Division of Human Genetics Diagnostic Laboratories) Joubert and Meckel-Gruber Syndromes via the CC2D2A gene CC2D2A Joubert syndrome 9 File Name: Gilfix-Lab Send Out List_Revised Updated Page 14 of 30

15 APPELATION APPROUVÉE DE OU DE LA MALADIE ASSOCIÉE JUNCTIONAL EPIDERMOLYSIS BULLOSA (JEB) SANGER panel LAMC2; LAMA3; LAMB3; COL17A ; ; ; Juvenile Polyposis Syndrome ( and ) BMPR1A Juvenile Polyposis Syndrome ( and ) BMPR1A; SMAD ; Tier 2: Tier 1: & GeneDx GeneDx Juvenile Polyposis Syndrome ( and ) BMPR1A; SMAD ; Tier 3: GeneDx Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome/juvenile polyposis syndrome, infantile form KCNA1 Full Gene Sequencing Analysis (MOL064) KCNA SMAD4; BMPR1A ; Episodic ataxia/myokymia syndrome Tier 1: sequecning and GeneDx Medical Neurogenetics LAMINOPATHIES VIA THE LMNA GENE LMNA Charcot-Marie-Tooth Disease Type 2B1 (605588); Limb-Girdle Muscular Dystrophy, Type 1B (159001); Lipodystrophy, Familial Partial, Dunnigan Type (151660); Dilated Cardiomyopathy 1A (115200); Emery- Dreifuss Muscular Dystrophy, Autosomal Dominan (151350)t; Restrictive Dermopathy, Lethal (275210); Hutchinson-Gilford Syndrome (176670) File Name: Gilfix-Lab Send Out List_Revised Updated Page 15 of 30

16 APPELATION APPROUVÉE DE OU DE LA MALADIE ASSOCIÉE Lebers hereditary optic neuropathy (LHON) (535000) LEMS (anti-vgcc) Antibody Test Lambert-Eaton Myasthenic syndrome Red Top Leukemia, Philadelphia chromosome-positive, resistant to imatinib ABL Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation (611105) Levetiracetam LHON mtdna Evaluation LIMB GIRDLE MUSCULAR DYSTROPHY, TYPE 2L (LGMD2L)(611307) AND DISTAL MIYOSHI MYOPATHY (MMD3) (613319) VIA THE ANO5 GENE DARS Leber's hereditary optic neuropathy (535000); multiple mitochondrial genes involved ; transport on ice ANO Loeys-Dietz syndrome ( and ) TGFBR Loeys-Dietz syndrome ( and ) TGFBR Targeted mutation analysis gene gene London Health Sciences Centre, Molecular Diagnostic Laboratory University Health Network (Toronto General Hospital) Hopital Ste. Justine File Name: Gilfix-Lab Send Out List_Revised Updated Page 16 of 30

17 APPELATION APPROUVÉE DE OU DE LA MALADIE ASSOCIÉE Long QT Syndrome (LQTS) Sequencing and Gene Duplication Panel (192500) AKAP9, ANK2, CACNA1C, CAV3, KCNE1, KCNE2, KCNE3, KCNH2, KCNJ2, KCNQ1, SCN4B, SCN5A, SNTA1 TBC 1. Exon Array CGH, Next-gen Sequencing 2. Known mutation (specify mutation) GeneDx MAG 'Dual Antigen' Autoantibody Test Anti-MAG neuropathy, Anti-SGPG neuropathy Red Top Malignant hyperthermia susceptibility 1 (145600) RYR MAPT DNA Sequencing Test MAPT Frontotemporal Dementia (600274) Marfan syndrome, type I (154700) FBN Melnick-Needles Syndrome (309350) FLNA Motor Neuropathy Profile - Complete Co-GM1 Quattro, MAG 'Dual Antigen' Autoantibody Test, NS6S Antibody Test Red Top or Multiple Endocrine Neoplasia type 1 (131100) MEN & & University Health Network (Toronto General Hospital) Connective Tissue Gene Tests Emory Genetics Laboratory Alberta Mol Dx Laboratory (Calgary) Multiple Endocrine Neoplasia type 1 (131100) MEN (MLPA) Multiple endocrine neoplasia, type IV (610755) CDKN1B Alberta Mol Dx Laboratory (Calgary) File Name: Gilfix-Lab Send Out List_Revised Updated Page 17 of 30

18 APPELATION APPROUVÉE DE OU DE LA MALADIE ASSOCIÉE Muscular dystrophy, limb-girdle, type 2B (253601) DYSF gene MuSK Quantitative Titres Antibody Test (Muscular Dystrophy) Red Top MVista Blastomyces dermatitidis Quantitative Antigen EIA blastomycosis antigen Minimum 0.5 ml for urine and BALF, 1.0 ml for other body fluids MiraVista MVista Histoplasma capsulatum Quantitive Antigen EIA Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency Myelin Associated Glycoprotein (MAG) Antibody, IgM Myocardial Antibodies Minimum 0.5 ml for urine and BALF, 1.0 ml for other body fluids. MiraVista RAPSN Available as part of profile from Mitogen Advanced inflammatory cardiomyopathy Red Top ARUP Mayo Med Lab MYOFIBRILLAR MYOPATHY SANGER SEQUENCING PANEL CRYAB (123590); DES (125660); FLNC (102565); LDB3 (605906); MYOT (604103); BAG3 (603883) Myofibrillar Myopathy, ZASP-Related (609452); Myotilinopathy (609200); Myofibrillar Myopathy, Desmin- Related (601419); Alpha- B Crystallinopathy (608810); Myofibrillar Myopathy, Filamin C- Related (609524); Myofibrillar Myopathy, BAG3-Related (612954) File Name: Gilfix-Lab Send Out List_Revised Updated Page 18 of 30

19 APPELATION APPROUVÉE DE OU DE LA MALADIE ASSOCIÉE myopathy, congenital via the TPM3 gene TPM Nemaline myopathy 1, autosomal dominant (609284) and Congenital fiber type disproportion (255310) Myotonic muscular dystrophy, type 2 (602668) ZNF repeat expansion N-Acetylprocainamide Natural Killer (NK) Cell Cytotoxicity Assay Therapeutic: 22-72; Toxic: > 90 µmol/l hemophagocytic lymphohistiocytosis (HLH) Childern's Hospital of Eastern Ontario Red Top; FPIA Integra Hospitals-In-Common Children (Rapid Response Laboratory) Natural Killer (NK) Cell Degranulation Assay hemophagocytic lymphohistiocytosis (HLH) Children (Rapid Response Laboratory) Nemaline myopathy 1, autosomal dominant (609284) TPM3 (NEM1) Sequence analysis of the entire coding region and Deletion/duplicat ion analysis Emory Molecular Genetics Laboratory Neurofibromatosis Type 2 (NF2) Evaluation (101000) NF Neurofibromatosis Type I (NF1) Evaluation (162200) NF and and Neuromyelitis Optica Antibody (IgG) NMO-IgG; aquaporin 4 Red Top Hospitals-In-Common Neuron-specific enolase tumor marker Red Top, refrigerated Niemann-Pick Disease Type C via the NPC2 Gene (607625) NPC File Name: Gilfix-Lab Send Out List_Revised Updated Page 19 of 30

20 APPELATION APPROUVÉE DE OU DE LA MALADIE ASSOCIÉE Niemann-Pick diseasetype C via the NPC1 gene (257220) NPC NMDA (NR1) Receptor Antibodies Encelphalitis, CSF Mitogen Advanced N-Methylhistamine Urine, random or 24-h s Oculopharyngeal Muscular Dystrophy (164300) PABPN repeat expansion Oculophyaryngeal Muscular Dystrophy PABPN repeat sizing Childern's Hospital of Eastern Ontario Molecular GeneticsLlaboratory - BC Children s Hospital & BC Women s Hospital Oncotype DX FFPE gene expression Genomic Health Optic atrophy 3 (165300) OPA Optic Atrophy Evaluation (OPA1) OPA Optic atrophy I (165500) OPA gene Optic atrophy I (165500) OPA Osteogenesis imperfecta, type 1, 2, 3 & 4 COL1A1; COL1A ; Ovarian Dysgenesis via the FSHR gene (233300) FSHR Oxalate, Plasma Ovarian dysgenesis 1 (233300) Green Top; sample must be acidifired PALB2-Related cancer (114480) PALB and Emory Genetics Laboratory Emory Genetics Laboratory Connective Tissue Gene Test s Ambry Genetics File Name: Gilfix-Lab Send Out List_Revised Updated Page 20 of 30

21 APPELATION APPROUVÉE DE OU DE LA MALADIE ASSOCIÉE Pancreatic Polypeptide Plasma EDTA, fasting, handle 4 C Paraglioma SDHB SDHC SDHD s Alberta Mol Dx Laboratory (Calgary) Paraglioma SDHB Paraglioma SDHC Paraglioma SDHD Paramyotonia Congenita (168300) SCN4A Pelizaeus-Merzbacher disease and spastic paraplegia 2 ( and ) PLP Pepsinogen I Perforin PRF Perforin protein expression hemophagocytic lymphohistiocytosis (HLH), familial 2 (603553) hemophagocytic lymphohistiocytosis (HLH) (603553) Red Top or or Lavender (EDTA) Alberta Mol Dx Laboratory (Calgary) Alberta Mol Dx Laboratory (Calgary) Alberta Mol Dx Laboratory (Calgary) London Laboratories Service Group s Children (Rapid Response Laboratory) Children (Rapid Response Laboratory) Perforin/granzyme B Protein Expression primary hemophagocytic lymphohistiocytosis (HLH) TBD Cinncinatti Children's Hospital (Diagnostic Immunology Laboratories ) File Name: Gilfix-Lab Send Out List_Revised Updated Page 21 of 30

22 APPELATION APPROUVÉE DE OU DE LA MALADIE ASSOCIÉE Periodic Fevers Syndromes MEFV; TNFRSF1A; MVK ; ; Familial Mediterranean Fever (FMF) ( and ); TNF receptor-associated periodic syndrome (TRAPS (142680); Hyperimmunoglobulin D Syndrome (HIDS) (260920) Molecular GeneticsLlaboratory - BC Children s Hospital & BC Women s Hospital PNMA2 (Ma2/Ta) Paraneoplastic Disease Profile Pompe Disease (Glycogen storage disease II) (232300) GAA Porencephaly 1(175780) COL4A Porphobilinogen Deaminase Porphyrins Evaluation, Whole Blood Acute Intermittent Porphyria (176000) erythropoietic protoporphyria (177000) and congenital erythropoietic porphyria (163700) Green Top, 2 ml, 4 C only Green Top (heparin), fasting, handle 4 C. Must arrive within 3 days of drawing. Alternate: washed erthyrocytes gene Mitogen Advanced CHEO s Porphyrins, Total, plasma Porphyria cutanea tarda Green top (heparin); protect from light; transfer to amber vial s PROGRESSIVE BULBAR PALSY WITH OR WITHOUT SENSORINEURAL DEAFNESS [BROWN-VIALETTO-VAN LAERE SYNDROME (211530) AND FAZIO-LONDE DISEASE (211500)] VIA THE SLC52A3 (C20ORF54) SLC52A Not aavailable: SLC52A2 (607882) and SLC52A1 (607883) File Name: Gilfix-Lab Send Out List_Revised Updated Page 22 of 30

23 APPELATION APPROUVÉE DE OU DE LA MALADIE ASSOCIÉE Progressive external ophthalmoplegia (CPEO) (530000) POLG Kearns-Sayre syndrome GeneDx Progressive Familial Intrahepatic Cholestasis Type 1 (211600) ATP8B Cinncinatti Children's Hospital (Division of Human Genetics Diagnostic Laboratories) Proinsulin, Plasma Plasma (EDTA) s PTEN hamartoma tumor syndrome PTEN & GeneDx Q Fever Antibody Red Top RAPSYN-related disorders via the RAPSN gene (466) RAPSN Congenital myasthenic syndromes (608931); Fetal Akinesia Deformation Sequence (208150) Recombx Zic4 Antibody Test paraneoplastic syndrome Red Top Recoverin Paraneoplastic Disease Profile Retinoblastoma (180200) RB Retinol Binding Protein Rifabutin Red-top tube(s) or a serum gel tube or urine Serum Mitogen Advanced Children Quest /Nichols Institute National Jewish Health Laboratories File Name: Gilfix-Lab Send Out List_Revised Updated Page 23 of 30

24 APPELATION APPROUVÉE DE OU DE LA MALADIE ASSOCIÉE SAP (XLP1) Protein expression SH2D1A X-linked lymphoproliferative syndrome (XLP1) (308240) TBD Cinncinatti Children's Hospital (Diagnostic Immunology Laboratories ) SCA3/Machado Joseph disease (109150) ATNX SCA Panel available North York General Secretin EDTA plasma containing the G.I. Preservative Freeze InterScience Institute immediately Selenoprotein N, 1 via the SEPN1 gene SEPN Muscular dystrophy, rigid spine, 1 (602771) SH3TC2 DNA Sequencing Test SH3TC SLC40A1-Related Hereditary Hemochromatosis (606069) SLC40A Charcot-Marie-Tooth disease, type 4C (601596) ferroportin; Hereditary Hemochromatosis type IV (606069) gene Small Fiber Painful Axonal Neuropathy Profile Peripheral Neuropathy; Detection of anti-hu antibodies using recombinant human antigens, anti-sulfatide antibodies and mutations in the transthyretin gene Red Top AND Small Fibre Painful Axonal Neuropathy Profile peripheral neuropathy: anti-hu, anti-sulfatide, & TTR Red Top AND Soluble CD 163 hemophagocytic lymphohistiocytosis (HLH) Children (Rapid Response Laboratory) File Name: Gilfix-Lab Send Out List_Revised Updated Page 24 of 30

25 APPELATION APPROUVÉE DE OU DE LA MALADIE ASSOCIÉE Soluble IL-2 Receptor (CD25) Somatostatin (Somatotropin Release-Inhibiting Factor, SRIF) hemophagocytic lymphohistiocytosis (HLH) EDTA plasma containing the G.I. Preservative. Freze immediately. Spastic ataxia, Charlevoix-Saguenay type (270550) SACS Spastic paraplegia 11, autosomal recessive SPG Spastic paraplegia 11/Spastic ataxia, Charlevoix-Saguenay type /Spastic paraplegia 5A, autosomal recessive SPG11; SACS; CYP7B ; ; AR Hereditary Spastic Paraplegia panel A Spastic paraplegia 3A, autosomal dominant (182600) ATL Spastic paraplegia 4, autosomal dominant (182601) SPAST Spastic paraplegia 7, autosomal recessive SPG Spermatogenic Failure-6 (102530) PGF6 (SPATA16) Panel A; and gene gene Panel B; and gene Children (Rapid Response Laboratory) InterScience Institute Children Children Children Children File Name: Gilfix-Lab Send Out List_Revised Updated Page 25 of 30

26 APPELATION APPROUVÉE DE OU DE LA MALADIE ASSOCIÉE Spermatogenic Failure-9 (613958) DPY19L gene Spinal and bulbar muscular atrophy of Kennedy (313200) AR Repeat analysis Children Spinocerebellar Ataxia (SCA) Panel (1,2,3,6,7,8,17) North York General Spinocerebellar ataxia 1 (601556) ATXN SCA Panel available North York General Spinocerebellar ataxia 11 (604432) TTBK gene Spinocerebellar ataxia 17 (607136) TBP SCA Panel available North York General Spinocerebellar ataxia 2 (183090) ATXN SCA Panel available North York General Spinocerebellar ataxia 6 (183086) CACNA1A SCA Panel available triplet expansion North York General Spinocerebellar ataxia 6 (183086) CACNA1A SCA Panel available triplet expansion North York General Spinocerebellar ataxia 7 (607640) ATXN SCA Panel available Spinocerebellar ataxia 8 (608768) ATXN SCA Panel available Spinocerebellar ataxia type 27 (609307) FGF gene North York General North York General File Name: Gilfix-Lab Send Out List_Revised Updated Page 26 of 30

27 APPELATION APPROUVÉE DE OU DE LA MALADIE ASSOCIÉE Spinocerebellar ataxia, autosomal recessive-8 (French Canadain mutation sequecning panel) SYNE Autosomal recessive cerebellar ataxia 1 (ARCA1; OMIM ) Stickler syndrome, type 1 (609508); Legg-Calve-Perthes disease (150600) COL2A STK11 Gene Sequencing & Del/Dup STK Peutz-Jeghers syndrome (175200) and Connective Tissue Gene Test GeneDx Syntaxin 11 STX hemophagocytic lymphohistiocytosis (HLH) (603552) Children (Rapid Response Laboratory) Systemic Sclerosis (Scleroderma) Profile Mitogen Advanced T3 (Triiodothyronine), Total T4 (Thyroxine), Free Red top TCF1 (MODY3) DNA Sequencing and Deletion Test HNF1 (TCF1) MODY3, Maturity-Onset Diabetes of Young (MODY) (600496) Titanium ; transfer to plastic container Hospitals-In-Common Topiramate File Name: Gilfix-Lab Send Out List_Revised Updated Page 27 of 30 Red Top or Green Top or ; not SST Torsion Dystonia, Autosomal Dominant (128100) DYT Transthyretin amyloidosis (105210) TTR Targeted Mutation Analysis, Detects c.907_909delga G Hospitals-In-Common Alberta Mol Dx Laboratory (Calgary) Molecular GeneticsLlaboratory - BC Children s Hospital & BC Women s Hospital

28 APPELATION APPROUVÉE DE OU DE LA MALADIE ASSOCIÉE Trifluoperazine (stelazine) Drug Screen, Prescription/OTC Random urine Trimethylamine (TMA) and TMA N-oxide (TMAO), Quantitative, Urine trimethylaminuria Morning void urine. Freeze immediately. Denver Genetics Laboratory Trypsinogen serum Hospitals-In-Common Type 6 Collagenopathy via the COL6A1 gene COL6A Type VI Collagenopathy Sequencing Panel UDP-Glucuronosyl Transferase 1A1 (UGT1A1), Full Gene Sequencing, Hyperbilirubinemia COL6A1, COL6A2, COL6A ; ; UGT1A UDP-Glucuronosyl Transferase 1A1 TA Repeat Genotype UGT1A Uroporphyrinogen Decarboxylase VALOSIN-CONTAINING PROTEIN-RELATED DISORDERS VIA THE VCP GENE VCP Ullrich congenital muscular dystrophy (254090) and Bethlem myopathy (158810) Ullrich congenital muscular dystrophy (254090) and Bethlem myopathy (158810) diagnosis of Gilbert (143500) or Crigler- Najjar syndromes ( and ) irinotecan sensitivity; diagnosis of Gilbert syndrome (143500) Porphyria Cutanea Tarda (176100) Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia (167320) Green top, 2 ml, 4 C only Valproic acid - free serum (not SST) Hospitals-In-Common Vascular Endothelial Growth Factor (VEGF) Lavender-top (EDTA) tube Quest /Nichols Institute File Name: Gilfix-Lab Send Out List_Revised Updated Page 28 of 30

29 APPELATION APPROUVÉE DE OU DE LA MALADIE ASSOCIÉE Vasoactive Intestinal Polypeptide (VIP) ; fasting; spin down & transfre to plastic vial; freeze immediately VGKC antibodies Paraneoplastic Disease Mitogen Advanced Vitamin B1 Vitamin B2 Vitamin B3 Vitamin B6 thiamin; to assess body stores riboflavin niacin (nictonic acid) pyridoxine Whole Blood (EDTA); not SST; protect from light; fasting Green Top; transfer to amber container; protect from light Plasma (EDTA); not SST; transfer to amber container; protect from light Plasma (EDTA or Li heparin); not SST; protect from light von Hippel-Lindau syndrome (193300) VHL von Willebrand disease (193400) VWF and Sequence analysis of select exons Hospitals-In-Common Hospitals-In-Common Alberta Mol Dx Laboratory (Calgary) ARUP Laboratories File Name: Gilfix-Lab Send Out List_Revised Updated Page 29 of 30

30 APPELATION APPROUVÉE DE OU DE LA MALADIE ASSOCIÉE Warburg Micro Syndrome (600118) RAB3GAP Also available: 1. Warburg Micro syndrome Sequencing panel (RAB3GAP1, RAB3GAP2 and RAB18 ) 2. Warburg Micro syndrome Deletion/Duplication panel (RAB3GAP1, RAB3GAP2 and RAB18 del/dup) Wilson Disease (277900) ATP7B Wolfram syndrome (222300) WFS X-linked Adrenoleukodystrophy (300100) ABCD Part of NGS panel: Combined Mito Genome Plus Mito 140 Nuclear Gene Panel (615) and University of Chicago Genetic Services Laboratories GeneDx Emory Molecular Genetics Laboratory File Name: Gilfix-Lab Send Out List_Revised Updated Page 30 of 30

Comprehensive List of Neuromuscular Disorders Covered by Muscular Dystrophy Canada

Comprehensive List of Neuromuscular Disorders Covered by Muscular Dystrophy Canada Comprehensive List of Neuromuscular Disorders Covered by Muscular Dystrophy Canada Neuromuscular disorders is a general term that refers to diseases that affect any part of the nerve and muscle. These

More information

LISTE DES ANALYSES HORS-QUEBEC List for testing done out of Québec LABORATOIRE CLINIQUES CUSM MUHC CLINICAL LABS

LISTE DES ANALYSES HORS-QUEBEC List for testing done out of Québec LABORATOIRE CLINIQUES CUSM MUHC CLINICAL LABS APPELATION APPROUVÉE DE OU DE LA MALADIE 11-ß-prostaglandin F2α 21-Hydroxylase Antibodies, Serum [OH21] 68kD (hsp-70) [F68KD] a1-acid glycoprotein autoimmume adrenal failure autoimmune hearing loss Obsolete

More information

LISTE DES ANALYSES HORS-QUEBEC List for testing done out of Québec LABORATOIRE CLINIQUES CUSM MUHC CLINICAL LABS

LISTE DES ANALYSES HORS-QUEBEC List for testing done out of Québec LABORATOIRE CLINIQUES CUSM MUHC CLINICAL LABS 11 Beta-Prostaglandin F2 Alpha, 24 Hour, Urine [BPG2] Systemic mast cell disease Urine. Add to container 25 ml 50% HAc. Collect for 24-h. Refrigeate 4 C during collection. Store frozen. Enzyme Immunoassay

More information

Objectives Role of Medical Genetics in Hearing Loss Evaluation. 5 y.o. boy with severe SNHL

Objectives Role of Medical Genetics in Hearing Loss Evaluation. 5 y.o. boy with severe SNHL Objectives Role of Medical Genetics in Hearing Loss Evaluation Millan Patel, MD UBC Dept. of Medical Genetics October 22, 2010 Case presentation to illustrate importance of defining syndromic hearing loss

More information

L E A D I N G C N S A N T I B O D Y T E S T I N G S E R V I C E S

L E A D I N G C N S A N T I B O D Y T E S T I N G S E R V I C E S L E A D I N G C N S A N T I B O D Y T E S T I N G S E R V I C E S Paraneoplastic Autoimmune Neurological Disorder Testing Services New Tests Now Available. Why Athena Diagnostics? Faster, More Relevant

More information

DIAGNOSING CHILDHOOD MUSCULAR DYSTROPHIES

DIAGNOSING CHILDHOOD MUSCULAR DYSTROPHIES DIAGNOSING CHILDHOOD MUSCULAR DYSTROPHIES Extracts from a review article by KN North and KJ Jones: Recent advances in diagnosis of the childhood muscular dystrophies Journal of Paediatrics and Child Health

More information

TEST AND PRICE LIST FOR NEXT GENERATION SEQUENCING

TEST AND PRICE LIST FOR NEXT GENERATION SEQUENCING AIP ALK APC Mutation Detection Techniques Ai Saple Type TAT ATM BAP1 BLM BMPR1A BRCA1 BRCA2 BRIP1 BUB1B CDC73 CDH1 CDK4 CDKN1C CDKN2A CEBPA CEP57 CHEK2 CYLD DDB2 DICER1 DIS3L2 EGFR EPCAM ERCC2 ERCC3 ERCC4

More information

Neuromuscular diseases

Neuromuscular diseases Neuromuscular diseases Spinal muscular atrophy - SMA characterized by degeneration of the anterior horn cells in the spinal cord and motor nuclei in the lower brainstem. SMA type 1, is also known as Werdnig-

More information

Test Information Sheet

Test Information Sheet Test Information Sheet GeneDx 207 Perry Parkway Gaithersburg, MD 20877 Phone: 888-729-1206 Fax: 301-710-6594 E-mail: wecare@genedx.com www.genedx.com/oncology OncoGene Dx: High/Moderate Risk Panel Sequence

More information

Paraneoplastic Antibodies in Clinical Practice. Mohammed El lahawi New Cross Hospital Wolverhampton

Paraneoplastic Antibodies in Clinical Practice. Mohammed El lahawi New Cross Hospital Wolverhampton Paraneoplastic Antibodies in Clinical Practice Mohammed El lahawi New Cross Hospital Wolverhampton 1 Effects of Neoplasm Direct mass ( pressure ) effect Metastasis effect Remote effect 2 The Nervous System

More information

The Genetics of Early- Onset Breast Cancer. Cecelia Bellcross, Ph.D., M.S.,C.G.C. Department of Human Genetics Emory University School of Medicine

The Genetics of Early- Onset Breast Cancer. Cecelia Bellcross, Ph.D., M.S.,C.G.C. Department of Human Genetics Emory University School of Medicine The Genetics of Early- Onset Breast Cancer Cecelia Bellcross, Ph.D., M.S.,C.G.C. Department of Human Genetics Emory University School of Medicine All cancers are genetic BUT Not all cancers are hereditary

More information

Single Gene and NextGen Panels

Single Gene and NextGen Panels Molecular Testing for Hearing Loss: Single Gene and NextGen Panels Honey V Reddi, PhD, FACMG Clinical Molecular Geneticist Prevention Genetics, Marshfield, WI www.preventiongenetics.com Outline of Presentation

More information

Molecular Genetic Testing in Public Health and Clinical Settings

Molecular Genetic Testing in Public Health and Clinical Settings Molecular Genetic Testing in Public Health and Clinical Settings Ira M. Lubin, PhD, FACMG Division of Laboratory Systems NCPDCID, CCID Centers for Disease Control and Prevention Atlanta, Georgia Disclaimers

More information

The NeurOmics team at a recent project meeting

The NeurOmics team at a recent project meeting Introduction Welcome to the NeurOmics project newsletter. This is the second edition and comes after the project has been underway for just over a year. This means that whilst we still have lots of work

More information

Next-generation sequencing can replace Sanger sequencing in clinical diagnostics.

Next-generation sequencing can replace Sanger sequencing in clinical diagnostics. Next-generation sequencing can replace Sanger sequencing in clinical diagnostics. Birgit Sikkema-Raddatz Department of Genetics, University Medical Center Groningen The Netherlands Groningen GRONINGEN

More information

Neonatal Hypotonia. Clinical Approach to Floppy Baby

Neonatal Hypotonia. Clinical Approach to Floppy Baby Neonatal Hypotonia Clinical Approach to Floppy Baby Hypotonia in the newborn is a common presenting feature of systemic illness or neurologic dysfunction at any level of the central or peripheral nervous

More information

ICD-10 coding rules for rare diseases

ICD-10 coding rules for rare diseases October 2014 ICD-10 coding rules for rare diseases Procedural document www.orpha.net Table of contents Table of contents... 2 General points... 3 I. Purpose... 3 II. Reference documents... 3 III. Range

More information

GENETIC TESTING FOR INHERITED MUTATIONS OR SUSCEPTIBILITY TO CANCER OR OTHER CONDITIONS MED207.110

GENETIC TESTING FOR INHERITED MUTATIONS OR SUSCEPTIBILITY TO CANCER OR OTHER CONDITIONS MED207.110 GENETIC TESTING FOR INHERITED MUTATIONS OR SUSCEPTIBILITY TO CANCER OR OTHER CONDITIONS MED207.110 COVERAGE: Pre- and post-genetic test counseling may be eligible for coverage in addition to the genetic

More information

CLINICAL GUIDELINES. Lab Management Program. Effective January 15, 2016

CLINICAL GUIDELINES. Lab Management Program. Effective January 15, 2016 CLINICAL GUIDELINES Lab Management Program Effective January 15, 2016 CareCore National, LLC d/b/a evicore healthcare (evicore) Clinical guidelines for medical necessity review of lab management services.

More information

ICD-9 to ICD-10 Conversion Commonly Used Neurologic Diagnosis

ICD-9 to ICD-10 Conversion Commonly Used Neurologic Diagnosis ICD-9 to ICD-10 Conversion Commonly Used Neurologic Diagnosis 327.20 Organic sleep apnea, unspecified... 1 331.0 Alzheimer s disease...3 333.1 Essential and other specified forms of tremor...4 340 Multiple

More information

Common Cancers & Hereditary Syndromes

Common Cancers & Hereditary Syndromes Common Cancers & Hereditary Syndromes Elizabeth Hoodfar, MS, LCGC Regional Cancer Genetics Coordinator Kaiser Permanente Northern California Detect clinical characteristics of hereditary cancer syndromes.

More information

Genetics and Cardiovascular diseases. Majid Alfadhel Geneticist and Pediatrician MD,MHSc,SSC Ped, ABHS(CH), FCCMG

Genetics and Cardiovascular diseases. Majid Alfadhel Geneticist and Pediatrician MD,MHSc,SSC Ped, ABHS(CH), FCCMG Genetics and Cardiovascular diseases Majid Alfadhel Geneticist and Pediatrician MD,MHSc,SSC Ped, ABHS(CH), FCCMG Outlines Basic understanding of cardiovascular genetics Modes of disease inheritance Genetic

More information

Management in the pre-hospital setting

Management in the pre-hospital setting Management in the pre-hospital setting Inflammation of the joints Two main types: Osteoarthritis - cartilage loss from wear and tear Rheumatoid arthritis - autoimmune disorder Affects all age groups,

More information

PART 2. ELECTRODIAGNOSTIC DIFFERENTIAL DIAGNOSIS OF COMMON

PART 2. ELECTRODIAGNOSTIC DIFFERENTIAL DIAGNOSIS OF COMMON PART 2. ELECTRODIAGNOSTIC DIFFERENTIAL DIAGNOSIS OF COMMON SYMPTOMS AND SIGNS 1. PAIN FACIAL PAIN " lesion of the trigeminal nerve " trigeminal neuralgia " facial nerve lesion NECK PAIN " C5 radiculopathy

More information

Hereditary Breast Cancer Testing. Diagnostic

Hereditary Breast Cancer Testing. Diagnostic Hereditary Cancer Testing Diagnostic New solutions for hereditary breast cancer. Identifying and understanding the genetic contribution to breast cancer allows for individualized disease management and

More information

Mendelian inheritance and the

Mendelian inheritance and the Mendelian inheritance and the most common genetic diseases Cornelia Schubert, MD, University of Goettingen, Dept. Human Genetics EUPRIM-Net course Genetics, Immunology and Breeding Mangement German Primate

More information

Test Information Sheet

Test Information Sheet Test Information Sheet GeneDx 207 Perry Parkway Gaithersburg, MD 20877 Phone: 888-729-1206 Fax: 301-710-6594 E-mail: wecare@genedx.com www.genedx.com/oncology OncoGene Dx: Breast/Ovarian Cancer Panel Sequence

More information

Launching a Cancer Genetic Laboratory to Enhance Diagnosis and Treatment

Launching a Cancer Genetic Laboratory to Enhance Diagnosis and Treatment Launching a Cancer Genetic Laboratory to Enhance Diagnosis and Treatment Arthur L. Beaudet, M.D. Department of Molecular and Human Genetics Baylor College of Medicine ORIGIN AND PRECEDENT Decades of experience

More information

Approaches to Integrating Next Generation Sequencing into the Electronic Health Record

Approaches to Integrating Next Generation Sequencing into the Electronic Health Record AMIA Webinar April 16, 2014 Approaches to Integrating Next Generation Sequencing into the Electronic Health Record Peter Tarczy-Hornoch, University of Washington On behalf of the Clinical Sequencing Exploratory

More information

INTRODUCTION TO THE UK CURRICULUM IN CLINICAL GENETICS

INTRODUCTION TO THE UK CURRICULUM IN CLINICAL GENETICS INTRODUCTION TO THE UK CURRICULUM IN CLINICAL GENETICS Clinical Geneticists work in multidisciplinary regional genetic centres in the UK, in close collaboration with laboratory scientists, clinical co-workers

More information

IMMEDIATE HOT LINE: Effective March 2, 2015

IMMEDIATE HOT LINE: Effective March 2, 2015 MEDICARE COVERAGE OF LABORATORY TESTING Please remember when ordering laboratory tests that are billed to Medicare/Medicaid or other federally funded programs, the following requirements apply: 1. Only

More information

Corporate Medical Policy Genetic Testing for Hereditary Hearing Loss

Corporate Medical Policy Genetic Testing for Hereditary Hearing Loss Corporate Medical Policy Genetic Testing for Hereditary Hearing Loss File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_testing_for_hereditary_hearing_loss 10/2013 8/2015 8/2016

More information

Progress and Prospects in Ovarian Cancer Screening and Prevention

Progress and Prospects in Ovarian Cancer Screening and Prevention Progress and Prospects in Ovarian Cancer Screening and Prevention Rebecca Stone, MD MS Assistant Professor Kelly Gynecologic Oncology Service The Johns Hopkins Hospital 1 No Disclosures 4/12/2016 2 Ovarian

More information

Neuromuscular Medicine Fellowship Curriculum

Neuromuscular Medicine Fellowship Curriculum Neuromuscular Medicine Fellowship Curriculum General Review Goals and Objectives Attend weekly EMG sessions as assigned Take a Directed History and Exam of each EMG patient Attend every other week Muscle

More information

2013/14 NHS STANDARD CONTRACT FOR DIAGNOSTIC SERVICE FOR RARE NEUROMUSCULAR DISORDERS (ALL AGES)

2013/14 NHS STANDARD CONTRACT FOR DIAGNOSTIC SERVICE FOR RARE NEUROMUSCULAR DISORDERS (ALL AGES) D04/S(HSS)/a 2013/14 NHS STANDARD CONTRACT FOR DIAGNOSTIC SERVICE FOR RARE NEUROMUSCULAR DISORDERS (ALL AGES) PARTICULARS, SCHEDULE 2 THE SERVICES, A - SERVICE SPECIFICATIONS Service Specification No.

More information

Blood Testing Protocols. Disclaimer

Blood Testing Protocols. Disclaimer Blood Testing Protocols / Page 2 Blood Testing Protocols Here are the specific test protocols recommend by Dr. J.E. Williams. You may request these from your doctor or visit www.readyourbloodtest.com to

More information

NEALS Clinical Trials (Studies 1-5)

NEALS Clinical Trials (Studies 1-5) NEALS and NCRI Sample Repository Request Form Instructions & Descriptions The sample repository consists of serum, plasma, cerebrospinal fluid (CSF), urine, extracted DNA and whole blood samples from NEALS

More information

G. Shashidhar Pai, MD MUSC Children s Hospital Department of Pediatrics Division of Genetics

G. Shashidhar Pai, MD MUSC Children s Hospital Department of Pediatrics Division of Genetics G. Shashidhar Pai, MD MUSC Children s Hospital Department of Pediatrics Division of Genetics One of every 500 newborns has bilateral permanent sensorineural hearing loss 40 db which makes it the most common

More information

specific B cells Humoral immunity lymphocytes antibodies B cells bone marrow Cell-mediated immunity: T cells antibodies proteins

specific B cells Humoral immunity lymphocytes antibodies B cells bone marrow Cell-mediated immunity: T cells antibodies proteins Adaptive Immunity Chapter 17: Adaptive (specific) Immunity Bio 139 Dr. Amy Rogers Host defenses that are specific to a particular infectious agent Can be innate or genetic for humans as a group: most microbes

More information

Natalia Taborda Vanegas. Doc. Sci. Student Immunovirology Group Universidad de Antioquia

Natalia Taborda Vanegas. Doc. Sci. Student Immunovirology Group Universidad de Antioquia Pathogenesis of Dengue Natalia Taborda Vanegas Doc. Sci. Student Immunovirology Group Universidad de Antioquia Infection process Epidermis keratinocytes Dermis Archives of Medical Research 36 (2005) 425

More information

Becker Muscular Dystrophy

Becker Muscular Dystrophy Muscular Dystrophy A Case Study of Positional Cloning Described by Benjamin Duchenne (1868) X-linked recessive disease causing severe muscular degeneration. 100 % penetrance X d Y affected male Frequency

More information

Minicore (multicore) myopathy

Minicore (multicore) myopathy Minicore (multicore) myopathy Minicore myopathy, also called, multicore myopathy and multiminicore myopathy, falls under the umbrella of congenital myopathies. These are a group of conditions characterised

More information

The Compassionate Allowances Initiative (CAL)

The Compassionate Allowances Initiative (CAL) The Compassionate Allowances Initiative (CAL) CAL s objective is to quickly identify conditions that invariably meet Social Security disability standards CAL initiative began with a public outreach hearing

More information

Genetics and Breast Cancer. Elly Lynch, Senior Genetic Counsellor Manager, Austin Health Clinical Genetics Service

Genetics and Breast Cancer. Elly Lynch, Senior Genetic Counsellor Manager, Austin Health Clinical Genetics Service Genetics and Breast Cancer Elly Lynch, Senior Genetic Counsellor Manager, Austin Health Clinical Genetics Service Overview Background/Our Team What is the difference between sporadic/familial cancer? How

More information

Reference Range: 0.5-1.6 mmol/l (arterial) 0.7-2.1 mmol/l (venous) CPT Code: 83605

Reference Range: 0.5-1.6 mmol/l (arterial) 0.7-2.1 mmol/l (venous) CPT Code: 83605 LACTIC ACID Fasting, arterial specimen preferred. Please note whether arterial or venous. 0.5 ml heparinized plasma. Green top or PST must be drawn, placed on ice, and spun within 15 minutes. Immediately

More information

LAB MANAGEMENT CRITERIA. 1199SEIU Funds. Effective July 16, 2015

LAB MANAGEMENT CRITERIA. 1199SEIU Funds. Effective July 16, 2015 LAB MANAGEMENT CRITERIA 1199SEIU Funds Effective July 16, 2015 Clinical criteria for medical necessity review of lab management services. Please note the following: CPT Copyright 2015 American Medical

More information

NORD Guides for Physicians #1. Physician s Guide to. Tyrosinemia. Type 1

NORD Guides for Physicians #1. Physician s Guide to. Tyrosinemia. Type 1 NORD Guides for Physicians #1 The National Organization for Rare Disorders Physician s Guide to Tyrosinemia Type 1 The original version of this booklet was made possible by donations in honor of Danielle

More information

1199 SEIU Benefit Funds Laboratory Management Program PRIOR AUTHORIZATION CODE LIST FOR OUTPATIENT MOLECULAR AND GENOMIC LABORATORY TESTS

1199 SEIU Benefit Funds Laboratory Management Program PRIOR AUTHORIZATION CODE LIST FOR OUTPATIENT MOLECULAR AND GENOMIC LABORATORY TESTS 1199 SEIU Benefit Funds Laboratory Management Program PRIOR AUTHORIZATION CODE LIST FOR OUTPATIENT MOLECULAR AND GENOMIC LABORATORY TESTS Effective January 1, 2016 Administered by evicore healthcare Refer

More information

***Next Generation sequencing testing options available effective April 18 th, 2016***

***Next Generation sequencing testing options available effective April 18 th, 2016*** ***Next Generation sequencing testing options available effective April 18 th, 2016*** Genetic Test Next Generation Sequencing NF1-RASopathy Panel Testing NF1-only NGS testing and copy number analysis

More information

MEDICAL POLICY No. 91540-R10 GENETICS: COUNSELING, TESTING, SCREENING

MEDICAL POLICY No. 91540-R10 GENETICS: COUNSELING, TESTING, SCREENING GENETICS: COUNSELING, TESTING, SCREENING Effective Date: February 26, 2015 Review Dates: 8/07, 10/07, 8/08, 8/09, 10/09, 2/10, 8/10, 8/11, 10/11, 10/12, 10/13, 11/14 Date Of Origin: August 8, 2007 Status:

More information

Breast cancer and the role of low penetrance alleles: a focus on ATM gene

Breast cancer and the role of low penetrance alleles: a focus on ATM gene Modena 18-19 novembre 2010 Breast cancer and the role of low penetrance alleles: a focus on ATM gene Dr. Laura La Paglia Breast Cancer genetic Other BC susceptibility genes TP53 PTEN STK11 CHEK2 BRCA1

More information

University of Cincinnati and Cincinnati Children s Hospital Medical Center. Genetic Counseling Program M.S.

University of Cincinnati and Cincinnati Children s Hospital Medical Center. Genetic Counseling Program M.S. University of Cincinnati and Cincinnati Children s Hospital Medical Center Genetic Counseling Program M.S. What is genetic counseling? Genetic counseling is the process of helping people understand and

More information

Gene Therapy. The use of DNA as a drug. Edited by Gavin Brooks. BPharm, PhD, MRPharmS (PP) Pharmaceutical Press

Gene Therapy. The use of DNA as a drug. Edited by Gavin Brooks. BPharm, PhD, MRPharmS (PP) Pharmaceutical Press Gene Therapy The use of DNA as a drug Edited by Gavin Brooks BPharm, PhD, MRPharmS (PP) Pharmaceutical Press Contents Preface xiii Acknowledgements xv About the editor xvi Contributors xvii An introduction

More information

Central core disease

Central core disease Central core disease Central core disease falls under the umbrella of congenital myopathies which are characterised by muscle weakness and wasting. It is a rare condition, and symptoms are usually present

More information

ACMG Practice Guideline

ACMG Practice Guideline June 2007 Vol. 9 No. 6 ACMG Practice Guideline Indications for genetic referral: a guide for healthcare providers Beth A. Pletcher, MD 1, Helga V. Toriello, PhD 2, Sarah J. Noblin, MS, CGC 3, Laurie H.

More information

Targeted Variant Test Requisition Form (3/4/2015)

Targeted Variant Test Requisition Form (3/4/2015) Targeted Variant Test Requisition Form (3/4/2015) Instructions: Please provide clinical features of family members. All testing must be ordered by a qualified healthcare provider. See Test Selection Box

More information

Tumour Markers. What are Tumour Markers? How Are Tumour Markers Used?

Tumour Markers. What are Tumour Markers? How Are Tumour Markers Used? Dr. Anthony C.H. YING What are? Tumour markers are substances that can be found in the body when cancer is present. They are usually found in the blood or urine. They can be products of cancer cells or

More information

Autoimmunity and immunemediated. FOCiS. Lecture outline

Autoimmunity and immunemediated. FOCiS. Lecture outline 1 Autoimmunity and immunemediated inflammatory diseases Abul K. Abbas, MD UCSF FOCiS 2 Lecture outline Pathogenesis of autoimmunity: why selftolerance fails Genetics of autoimmune diseases Therapeutic

More information

Cord blood Banking Transplant List for One USA Bank - StemCyte www.stemcyte.com/cordblood-banking-transplant-list

Cord blood Banking Transplant List for One USA Bank - StemCyte www.stemcyte.com/cordblood-banking-transplant-list Cells4Life is the oldest and largest cord blood storage company in the UK. We are governed by some of the world's most stringent medical laws, and are currently the only stem cell storage company in the

More information

Service Definition with all Clinical Terms Service: Laprascopic Cholecystectomy Clinic (No Gallstones in bile duct)

Service Definition with all Clinical Terms Service: Laprascopic Cholecystectomy Clinic (No Gallstones in bile duct) Service Definition with all Clinical Terms Service: Laprascopic Cholecystectomy Clinic (No Gallstones in bile duct) Section 1 Service Details Service ID: 7540540 Service Comments: Referrer Alert: Service

More information

Briefing Paper: Cross-border EU healthcare directive. Scotland

Briefing Paper: Cross-border EU healthcare directive. Scotland Briefing Paper: Cross-border EU healthcare directive Scotland Briefing Paper: Cross-border EU healthcare directive if you are entitled to it here, then you can get it there. Introduction The EU Directive

More information

Corporate Medical Policy Carrier Testing for Genetic Disease

Corporate Medical Policy Carrier Testing for Genetic Disease Corporate Medical Policy Carrier Testing for Genetic Disease File Name: Origination: Last CAP Review: Next CAP Review: Last Review: carrier_testing_for_genetic_disease 12/2013 8/2015 8/2016 8/2015 Description

More information

The Types of stem cells: Totipotent Pluripotent Multipotent

The Types of stem cells: Totipotent Pluripotent Multipotent Stem Cells is the main material for building and regeneration of the body Stem cells are not differentiated and can transform to any cell of organism Stem cells are capable of indefinite renewal through

More information

6/10/2015. Hereditary Predisposition for Breast Cancer: Looking at BRCA1/BRCA2 Testing & Beyond. Hereditary Cancers. BRCA1 and BRCA2 Review

6/10/2015. Hereditary Predisposition for Breast Cancer: Looking at BRCA1/BRCA2 Testing & Beyond. Hereditary Cancers. BRCA1 and BRCA2 Review Hereditary Predisposition for Breast Cancer: Looking at BRCA1/BRCA2 Testing & Beyond Arturo Anguiano MD, FACMG International Medical Director, Medical Affairs Vice Chairman, Genetics; Medical Director,

More information

Covers 60 major critical illnesses. Covers 11 minor critical illnesses. ManuMulti Care

Covers 60 major critical illnesses. Covers 11 minor critical illnesses. ManuMulti Care It s a difficult subject to think about, but part of planning for the future is being prepared for the unexpected. Critical illness can happen to anyone, at any time. And it s an unfortunate fact, but

More information

Oculopharyngeal muscular dystrophy (OPMD)

Oculopharyngeal muscular dystrophy (OPMD) Oculopharyngeal muscular dystrophy (OPMD) The term muscular dystrophy is used to cover a wide range of conditions which have in common progressive muscle weakness due to an inherited genetic defect (mutation).

More information

***Next Generation sequencing testing options available effective April 18 th, 2016***

***Next Generation sequencing testing options available effective April 18 th, 2016*** ***Next Generation sequencing testing options available effective April 18 th, 2016*** Genetic Test Next Generation Sequencing NF1-RASopathy Panel Testing NF1-only NGS testing and copy number analysis

More information

Disclosures. Consultant and Speaker for Biogen Idec, TEVA Neuroscience, EMD Serrono, Mallinckrodt, Novartis, Genzyme, Accorda Therapeutics

Disclosures. Consultant and Speaker for Biogen Idec, TEVA Neuroscience, EMD Serrono, Mallinckrodt, Novartis, Genzyme, Accorda Therapeutics Mitzi Joi Williams, MD Neurologist MS Center of Atlanta, Atlanta, GA Disclosures Consultant and Speaker for Biogen Idec, TEVA Neuroscience, EMD Serrono, Mallinckrodt, Novartis, Genzyme, Accorda Therapeutics

More information

Clinical Trials of Disease Modifying Treatments

Clinical Trials of Disease Modifying Treatments MS CENTER CLINICAL RESEARCH The UCSF MS Center is an internationally recognized leader in multiple sclerosis clinical research. We conduct clinical trials involving the use of experimental treatments,

More information

A Source of Hard- to- Find Pa3ents and Caregivers For Researchers. Peter Ziedins Peter.ziedins@mpiresearch.ca 514-426- 9295 www.rarepa;entvoice.

A Source of Hard- to- Find Pa3ents and Caregivers For Researchers. Peter Ziedins Peter.ziedins@mpiresearch.ca 514-426- 9295 www.rarepa;entvoice. A Source of Hard- to- Find Pa3ents and Caregivers For Researchers Peter Ziedins Peter.ziedins@mpiresearch.ca 514-426- 9295 www.rarepa;entvoice.com About RPV Rare Pa3ent Voice, LLC was formed to provide

More information

UNIT 13 (OPTION) Genetic Abnormalities

UNIT 13 (OPTION) Genetic Abnormalities Unit 13 Genetic Abnormailities 1 UNIT 13 (OPTION) Genetic Abnormalities Originally developed by: Hildur Helgedottir RN, MN Revised (2000) by: Marlene Reimer RN, PhD, CCN (C) Associate Professor Faculty

More information

About The Causes of Hearing Loss

About The Causes of Hearing Loss About 1 in 500 infants is born with or develops hearing loss during early childhood. Hearing loss has many causes: some are genetic (that is, caused by a baby s genes) or non-genetic (such as certain infections

More information

Zika Virus. Fred A. Lopez, MD, MACP Richard Vial Professor Department of Medicine Section of Infectious Diseases

Zika Virus. Fred A. Lopez, MD, MACP Richard Vial Professor Department of Medicine Section of Infectious Diseases Zika Virus Fred A. Lopez, MD, MACP Richard Vial Professor Department of Medicine Section of Infectious Diseases What is the incubation period for Zika virus infection? Unknown but likely to be several

More information

dagan.wells@obs gyn.ox.ac.ukgyn.ox.ac.uk

dagan.wells@obs gyn.ox.ac.ukgyn.ox.ac.uk In vitro fertilisation and genetic testing Dagan Wells, PhD, FRCPath dagan.wells@obs gyn.ox.ac.ukgyn.ox.ac.uk Infertility Unprotected intercourse for 1 year without conception Very common 1 in 6 couples

More information

Genetic Testing in Research & Healthcare

Genetic Testing in Research & Healthcare We Innovate Healthcare Genetic Testing in Research & Healthcare We Innovate Healthcare Genetic Testing in Research and Healthcare Human genetic testing is a growing science. It is used to study genes

More information

EBiSC: The European Bank for induced pluripotent Stem Cells

EBiSC: The European Bank for induced pluripotent Stem Cells EBiSC: The European Bank for induced pluripotent Stem Cells Sadallah Fatiha 30.10.2014 Japan Health Sciences Foundation Visit IMI JU Office, Brussels, Belgium EBiSC Establish a European repository for

More information

Limb girdle muscular dystrophies (LGMDs)

Limb girdle muscular dystrophies (LGMDs) Limb girdle muscular dystrophies (LGMDs) This factsheet is for all people for whom a diagnosis of limb girdle muscular dystrophy (LGMD) has been suggested. This is a complicated subject since there are

More information

3nd Biennial Contemporary Clinical Neurophysiological Symposium October 12, 2013 Fundamentals of NCS and NMJ Testing

3nd Biennial Contemporary Clinical Neurophysiological Symposium October 12, 2013 Fundamentals of NCS and NMJ Testing 3nd Biennial Contemporary Clinical Neurophysiological Symposium October 12, 2013 Fundamentals of NCS and NMJ Testing Peter D. Donofrio, M.D. Professor of Neurology Vanderbilt University Medical Center

More information

P R O D U C T S CATALOG 2011-2012

P R O D U C T S CATALOG 2011-2012 P R O D U C T S CATALOG 2011-2012 INSTITUTE FOR THE APPLICATION OF NUCLEAR ENERGY - INEP Banatska 31b 11080 Zemun Belgrade Serbia Tel: (+381 11) 2619 252, 2618 696, 2199 949 Fax: (+381 11) 2618 724 www.inep.co.rs

More information

A Decision Support Tool to Facilitate Cancer Risk Assessment and Referral for Genetics Services. Kristen Vogel Postula, MS, CGC & Leigh Baumgart, PhD

A Decision Support Tool to Facilitate Cancer Risk Assessment and Referral for Genetics Services. Kristen Vogel Postula, MS, CGC & Leigh Baumgart, PhD A Decision Support Tool to Facilitate Cancer Risk Assessment and Referral for Genetics Services Kristen Vogel Postula, MS, CGC & Leigh Baumgart, PhD Importance of Family History Increasing awareness of

More information

Facts About. Metabolic. Diseases of Muscle

Facts About. Metabolic. Diseases of Muscle Facts About Metabolic Diseases of Muscle Updated December 2009 Keith Stout Dear Friends: If you ve just learned that you or a loved one has a metabolic muscle disorder, you re probably both relieved and

More information

Laboratory User Guides

Laboratory User Guides CLINICAL GENETIC SERVICE Laboratory User Guides (Website version) January 2016 DEPARTMENT OF HEALTH GOVERNMENT OF HONG KONG SAR Page 1 of 10 Compared with the previous version of January 2015, several

More information

2014 CPT Code Updates

2014 CPT Code Updates 2014 CPT Code Updates This publication is a summary of The American Medical Association Current Procedural Terminology (CPT) codes published in ARUP's Laboratory Test Directory effective January 1, 2014.

More information

Medical Devices; Exemptions From Premarket Notifications; Class II Devices; Autosomal

Medical Devices; Exemptions From Premarket Notifications; Class II Devices; Autosomal This document is scheduled to be published in the Federal Register on 10/27/2015 and available online at http://federalregister.gov/a/2015-27198, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN

More information

CNS DEMYLINATING DISORDERS

CNS DEMYLINATING DISORDERS CNS DEMYLINATING DISORDERS Multiple sclerosis A Dutch saint named Lidwina, who died in 1433, may have been one of the first known MS patients. After she fell while ice skating, she developed symptoms such

More information

GENETIC TESTING AND MARFAN SYNDROME

GENETIC TESTING AND MARFAN SYNDROME GENETIC TESTING AND MARFAN SYNDROME Genetic testing for mutations in fibrillin-1 (FBN1) and other genes has become an important and reliable option to aid in the diagnosis of Marfan syndrome and related

More information

Muscle Physiology and the. Pathology of Muscular Dystrophy

Muscle Physiology and the. Pathology of Muscular Dystrophy Muscle Physiology and the Pathology of Muscular Dystrophy Angela Tompkins February 23, 2010 Everglades University Biology 1 Muscle Physiology and the Pathology of Muscular Dystrophy Humans are able to

More information

Facts About. Friedreich s Ataxia

Facts About. Friedreich s Ataxia Facts About Friedreich s Ataxia Updated December 2009 Michelle Moffitt Smith Michelle and James Smith at their wedding Dear Friends: When I was about 14, I started having problems keeping my balance when

More information

Influences on Birth Defects

Influences on Birth Defects Influences on Birth Defects FACTS About 150,000 babies are born each year with birth defects. The parents of one out of every 28 babies receive the frightening news that their baby has a birth defect There

More information

Optional Tests Offered Before and During Pregnancy

Optional Tests Offered Before and During Pregnancy Plano Women s Healthcare Optional Tests Offered Before and During Pregnancy Alpha-Fetoprotein Test (AFP) and Quad Screen These are screening tests that can assess your baby s risk of having such birth

More information

Muscular dystrophy clinical manifestations: progressive proximal extremity weakness respiratory muscle weakness cardiomyopathy

Muscular dystrophy clinical manifestations: progressive proximal extremity weakness respiratory muscle weakness cardiomyopathy Muscular dystrophy clinical manifestations: progressive proximal extremity weakness respiratory muscle weakness cardiomyopathy Muscular dystrophy pathology: muscle fiber degeneration and regeneration Muscular

More information

Case Study: John Woodbury

Case Study: John Woodbury Case Presentation John is 44 years old. He is sitting in the chair in the examination room. As he moves to the table, he stumbles on the carpet, laughs at himself and says that happens all the time. John

More information

Genetic Tests and Disease States Included in Humana s Genetic Guidance Program

Genetic Tests and Disease States Included in Humana s Genetic Guidance Program 81161 81200 81201 Dystrophin (DMD) (e.g., Duchenne/Becker muscular dystrophy) deletion analysis and duplication analysis, if performed Aspartoacylase (ASPA) (e.g., Canavan disease) gene analysis, common

More information

Chronic pancreatitis Questions and answers. Dr. med. Bruno Strebel

Chronic pancreatitis Questions and answers. Dr. med. Bruno Strebel Chronic pancreatitis Questions and answers Dr. med. Bruno Strebel Question 1: Chronic pancreatitis What is the definition of chronic pancreatitis? Chronic pancreatitis Questions and answers 2 Question

More information

Patient Information. Ordering Physician Information. Indication for Testing (REQUIRED)

Patient Information. Ordering Physician Information. Indication for Testing (REQUIRED) EPILEPSY EXOME CLINICAL CHECKLIST REQUIRED Please check all clinical features that apply, and use the additional space provided at the bottom of the form if needed Patient Information Name: Last First

More information

SYDNEY CHILDREN'S HOSPITAL NETWORK - RANDWICK ALLIED HEALTH AMBULATORY/OUTPATIENT CLINICS & TEAMS April 2014

SYDNEY CHILDREN'S HOSPITAL NETWORK - RANDWICK ALLIED HEALTH AMBULATORY/OUTPATIENT CLINICS & TEAMS April 2014 Should you wish to enquire about any of the listed clinics please contact the relevant Allied Health Department Head. SYDNEY CHILDREN'S HOSPITAL NETWORK - RANDWICK ALLIED HEALTH AMBULATORY/OUTPATIENT CLINICS

More information

Hereditary Breast Cancer. Nicole Kounalakis, MD Assistant Professor of Surgery University of Colorado Medical Center

Hereditary Breast Cancer. Nicole Kounalakis, MD Assistant Professor of Surgery University of Colorado Medical Center Hereditary Breast Cancer Nicole Kounalakis, MD Assistant Professor of Surgery University of Colorado Medical Center Outline Background Assessing risk of patient Syndromes BRCA 1,2 Li Fraumeni Cowden Hereditary

More information

State and National Call Centers

State and National Call Centers State and National Call Centers Listed Alphabetical by Name Acadia Hospital Access Dept. 1-800-640-1211 AIDS 1-800-851-2437 AIDS Clinical Trials Information Service 1-800-874-2572 AIDS Hotline 1-800-851-2437

More information

MRI in Differential Diagnosis

MRI in Differential Diagnosis MRI in Differential Diagnosis Jill Conway, MD, MA, MSCE Director, Carolinas MS Center Clerkship Director, UNCSOM-Charlotte Campus Charlotte, NC DISCLOSURES Speaking, consulting, and/or advisory boards

More information

Neurology. Medical Staff: Children s Access Center. Outpatient Referral. Neurology Office Numbers

Neurology. Medical Staff: Children s Access Center. Outpatient Referral. Neurology Office Numbers Neurology The Neurology Practice at Children s Hospital Central California provides diagnostic services, medical treatment, and follow-up care to infants, children, and adolescents who have suspected or

More information